Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin–Frankfurt–Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen

Michael E. Rytting, Elias J. Jabbour, Jeffrey L. Jorgensen, Farhad Ravandi, Anna R. Franklin, Tapan M. Kadia, Naveen Pemmaraju, Naval G. Daver, Alessandra Ferrajoli, Guillermo Garcia-Manero, Marina Y. Konopleva, Gautam Borthakur, Rebecca Garris, Sa Wang, Sherry Pierce, Kurt Schroeder, Steven M. Kornblau, Deborah A. Thomas, Jorge E. Cortes, Susan M. O'BrienHagop M. Kantarjian

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Fingerprint Dive into the research topics of 'Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin–Frankfurt–Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen'. Together they form a unique fingerprint.

Medicine & Life Sciences